Lombard Odier Asset Management (Switzerland) SA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Switzerland) SA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2018$8,708,000
+33.9%
76,000
+4.8%
0.86%
+26.0%
Q2 2018$6,502,000
+186.1%
72,500
+11.9%
0.68%
+1081.0%
Q3 2014$2,273,00064,7790.06%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders